Xu Haoliang, Rewerska Julia, Aardsma Nathan, Slavin Konstantin, Valyi-Nagy Tibor, Ni Hongyu
Folia Neuropathol. 2017;55(3):221-226. doi: 10.5114/fn.2017.70487.
Primary central nervous system post-transplant lymphoproliferative disorder (PCNS-PTLD) is a rare complication with inferior survival outcomes in solid organ transplant patients. It represents approximately 7-15% of all PTLD patients. Because of the rarity of this disease, the diagnosis of PCNS-PTLD is often challenging, and the optimal therapy has not been established. We report a case of a renal transplant patient who initially presented with acute altered neurological function, an enhancing mass lesion of the brain on magnetic resonance imaging (MRI), and nonspecific reactive histopathological changes on brain biopsy. The lesion was self-limited and spontaneously resolved without medical treatment for PTLD. Six months later, surveillance MRI revealed recurrence of the brain lesion. The biopsy showed morphologic changes consistent with Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma. The patient responded well to reduction of immunosuppression and treatment with a single-agent regimen of rituximab. This is an unusual case of PCNS-PTLD with an initial presentation resembling a self-limited reactive lesion.
原发性中枢神经系统移植后淋巴组织增生性疾病(PCNS-PTLD)是实体器官移植患者中一种罕见的并发症,生存结局较差。它约占所有PTLD患者的7%-15%。由于这种疾病罕见,PCNS-PTLD的诊断往往具有挑战性,且尚未确立最佳治疗方法。我们报告一例肾移植患者,该患者最初表现为急性神经功能改变、磁共振成像(MRI)显示脑部有强化肿块病变,脑活检有非特异性反应性组织病理学改变。该病变为自限性,未经PTLD治疗即自发消退。6个月后,监测MRI显示脑部病变复发。活检显示形态学改变符合爱泼斯坦-巴尔病毒(EBV)阳性弥漫性大B细胞淋巴瘤。该患者对免疫抑制减量及利妥昔单抗单药治疗方案反应良好。这是一例不寻常的PCNS-PTLD病例,最初表现类似自限性反应性病变。